Search

Define range intervals using parentheses.
E.g. C7H(10-14)O(0-4)
± (example: 123 ± 1)
±  
±    
±    
Options
Single/Multi-component


Isotopically Labeled


Additional Filters

Search Hits Limit:
17 hits found.
Search terms: MF = 'C_{32}H_{39}ClN_{2}O_{3}'
IDStructureMolecular FormulaMolecular Weight# of Data Sources# of References# of PubMed# of RSC
17465739

4 of 7 defined stereocentres - 4/7 defined
InChI=1/C32H39ClN2O3/c1-31-12-5-13-32(21-37-32)28(31)18-25-26(30(36)38-27(25)19-31)20-34-14-16-35(17-15-34)29(22-6-3-2-4-7-22)23-8-10-24(33)11-9-23/h2-4,6-11,25-29H,5,12-21H2,1H3/t25-,26?,27-,28-,29?,31-,32?/m1/s1
C32H39ClN2O3535.11674400
17466064

6 of 8 defined stereocentres - 6/8 defined
InChI=1/C32H39ClN2O3/c1-21-7-6-14-31(2)19-26-27(29-32(21,31)38-29)25(30(36)37-26)20-34-15-17-35(18-16-34)28(22-8-4-3-5-9-22)23-10-12-24(33)13-11-23/h3-5,8-13,21,25-29H,6-7,14-20H2,1-2H3/t21-,25?,26+,27+,28?,29-,31+,32-/m0/s1
C32H39ClN2O3535.11674400
24574748
InChI=1/C32H39ClN2O3/c1-22-29(21-30(38-22)25-9-12-26(33)13-10-25)32(36)34-17-5-6-18-35-19-15-24(16-20-35)28-14-11-23-7-3-4-8-27(23)31(28)37-2/h9-14,21,24H,3-8,15-20H2,1-2H3,(H,34,36)
C32H39ClN2O3535.11673300
2718089

Double-bond stereo
InChI=1/C32H39ClN2O3/c1-2-3-4-5-6-7-8-9-10-11-12-17-31(36)35-34-24-29-28-16-14-13-15-25(28)20-23-30(29)38-32(37)26-18-21-27(33)22-19-26/h13-16,18-24H,2-12,17H2,1H3,(H,35,36)
C32H39ClN2O3535.11673300
3010671

Double-bond stereo
InChI=1/C32H39ClN2O3/c1-2-3-4-5-6-7-8-9-10-11-12-21-31(36)35-34-24-28-26-18-14-13-17-25(26)22-23-30(28)38-32(37)27-19-15-16-20-29(27)33/h13-20,22-24H,2-12,21H2,1H3,(H,35,36)
C32H39ClN2O3535.11673300
7896324

Double-bond stereo
InChI=1/C32H39ClN2O3/c1-2-3-4-5-6-7-8-9-10-11-12-17-31(36)35-34-24-29-28-16-14-13-15-25(28)20-23-30(29)38-32(37)26-18-21-27(33)22-19-26/h13-16,18-24H,2-12,17H2,1H3,(H,35,36)/b34-24+
C32H39ClN2O3535.11673300
7909418

Double-bond stereo
InChI=1/C32H39ClN2O3/c1-2-3-4-5-6-7-8-9-10-11-12-21-31(36)35-34-24-28-26-18-14-13-17-25(26)22-23-30(28)38-32(37)27-19-15-16-20-29(27)33/h13-20,22-24H,2-12,21H2,1H3,(H,35,36)/b34-24+
C32H39ClN2O3535.11673300
8047508

Charge
InChI=1/C32H39N2O3.ClH/c1-6-11-20-36-32(35)26-15-13-12-14-25(26)31-27-18-16-23(33(7-2)8-3)21-29(27)37-30-22-24(17-19-28(30)31)34(9-4)10-5;/h12-19,21-22H,6-11,20H2,1-5H3;1H/q+1;/p-1
C32H39ClN2O3535.11672200
3793496

0 of 7 defined stereocentres - 0/7 defined
InChI=1/C32H39ClN2O3/c1-21-7-6-10-24-19-27-28(30(36)32(21,24)2)26(31(37)38-27)20-34-15-17-35(18-16-34)29(22-8-4-3-5-9-22)23-11-13-25(33)14-12-23/h3-5,8-14,21,26-30,36H,6-7,15-20H2,1-2H3
C32H39ClN2O3535.11672200
2778853

0 of 8 defined stereocentres - 0/8 defined
InChI=1/C32H39ClN2O3/c1-21-7-6-14-31(2)19-26-27(29-32(21,31)38-29)25(30(36)37-26)20-34-15-17-35(18-16-34)28(22-8-4-3-5-9-22)23-10-12-24(33)13-11-23/h3-5,8-13,21,25-29H,6-7,14-20H2,1-2H3
C32H39ClN2O3535.11672200
2824189

0 of 7 defined stereocentres - 0/7 defined
InChI=1/C32H39ClN2O3/c1-31-12-5-13-32(21-37-32)28(31)18-25-26(30(36)38-27(25)19-31)20-34-14-16-35(17-15-34)29(22-6-3-2-4-7-22)23-8-10-24(33)11-9-23/h2-4,6-11,25-29H,5,12-21H2,1H3
C32H39ClN2O3535.11672200
22871522

5 of 7 defined stereocentres - 5/7 defined
InChI=1/C32H39ClN2O3/c1-21-7-6-10-24-19-27-28(30(36)32(21,24)2)26(31(37)38-27)20-34-15-17-35(18-16-34)29(22-8-4-3-5-9-22)23-11-13-25(33)14-12-23/h3-5,8-14,21,26-30,36H,6-7,15-20H2,1-2H3/t21-,26?,27+,28+,29?,30-,32+/m0/s1
C32H39ClN2O3535.11672200
17464663

3 of 7 defined stereocentres - 3/7 defined
InChI=1/C32H39ClN2O3/c1-21-7-6-10-24-19-27-28(30(36)32(21,24)2)26(31(37)38-27)20-34-15-17-35(18-16-34)29(22-8-4-3-5-9-22)23-11-13-25(33)14-12-23/h3-5,8-14,21,26-30,36H,6-7,15-20H2,1-2H3/t21?,26?,27-,28-,29?,30?,32-/m1/s1
C32H39ClN2O3535.11672200
24668207

0 of 1 defined stereocentres - 0/1 defined
InChI=1/C32H38N2O3.ClH/c1-36-27-13-8-23(9-14-27)5-3-2-4-19-34-31-16-10-25(33)21-29(31)30-22-28(15-17-32(30)34)37-20-18-24-6-11-26(35)12-7-24;/h6-9,11-15,17,22,25,35H,2-5,10,16,18-21,33H2,1H3;1H
C32H39ClN2O3535.11671100
8384377
InChI=1/C32H38N2O3.ClH/c1-23(2)37-29-14-9-26(10-15-29)32-24(3)30-21-27(35)11-16-31(30)34(32)22-25-7-12-28(13-8-25)36-20-19-33-17-5-4-6-18-33;/h7-16,21,23,35H,4-6,17-20,22H2,1-3H3;1H
C32H39ClN2O3535.11671100
8477670
InChI=1/C32H38N2O3.ClH/c1-24-30-22-29(36-3)16-17-31(30)34(32(24)26-10-14-27(35-2)15-11-26)23-25-8-12-28(13-9-25)37-21-20-33-18-6-4-5-7-19-33;/h8-17,22H,4-7,18-21,23H2,1-3H3;1H
C32H39ClN2O3535.11671100
9159528

4 of 4 defined stereocentres - 4/4 defined
InChI=1/C32H38N2O3.ClH/c1-3-14-34-24-8-6-5-7-22(24)23-18-32(36-16-4-2)26-17-21-11-12-25(35)29-27(21)31(32,30(37-29)28(23)34)13-15-33(26)19-20-9-10-20;/h5-8,11-12,20,26,30,35H,3-4,9-10,13-19H2,1-2H3;1H/t26-,30-,31-,32+;/m0./s1
C32H39ClN2O3535.11671300
Feedback Form